1
1b
2
2
H), 6.69 (t, J = 7.32 Hz, 1H), 7.11–7.13 (m, 2H), 7.27–7.29 (m,
H), 7.75 (d, J = 8.28 Hz, 2H).
N-(2-Azidocyclohexyl)-4-methylbenzenesulfonamide
(2u).
1
H NMR (500 MHz, CDCl
3
): d 1.18–1.31 (m, 4H), 1.63–1.68 (m,
H), 2.00–2.03 (m, 2H), 2.43 (s, 3H), 2.92–2.96 (m, 1H), 3.08–3.10
m, 1H), 5.18 (d, J = 6.25 Hz, 1H), 7.31 (d, J = 8.28, 2H), 7.81
2
(
(
N-(2-(4-Methoxyphenylamino)cyclohexyl)-4-methylbenzenesul-
7
1
fonamide (2m). H NMR (500 MHz, CDCl
3
): d 0.97–1.00 (m,
d, J = 8.28 Hz, 2H).
1
2
5
8
H), 1.21–1.31 (m, 3H), 1.65–1.67 (m, 2H), 2.05–2.12 (m, 2H),
11b
.46 (s, 3H), 2.80–2.83 (m, 1H), 2.90–2.92 (m, 2H), 3.75 (s, 3H),
.01 (d, J = 4.1 Hz, 1H), 6.46 (d, J = 8.8 Hz, 2H), 6.75 (d, J =
.9 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H).
N-(2-Chlorocyclohexyl)-4-methylbenzenesulfonamide
H NMR (400 MHz, CDCl ): d 1.20–1.30 (m, 3H), 1.61–1.71 (m,
3H), 2.12–2.27 (m, 2H), 2.43 (s, 3H), 3.11–3.12 (m, 1H), 3.72–3.74
m, 1H), 5.20 (d, J = 4.88 Hz, 1H), 7.30 (d, J = 7.84 Hz, 2H),
(2v).
1
3
(
7
N-(2-(4-Fluorophenylamino)cyclohexyl)-4-methylbenzenesulfo-
.78 (d, J = 8.32 Hz, 2H).
7
1
namide (2n). H NMR (400 MHz, CDCl
3
): d 1.04–1.29 (m, 4H),
11b
1
3
6
.64–1.66 (m, 2H), 1.97–1.98 (m, 1H), 2.13–2.17 (m, 1H), 2.42 (s,
N-(2-Azidocyclopentyl)-4-methylbenzenesulfonamide
H NMR (500 MHz, CDCl ): d 1.36–1.41 (m, 1H), 1.59–1.69 (m,
3H), 1.95–2.00 (m, 2H), 2.44 (s, 3H), 3.37–3.42 (m, 1H), 3.70–3.73
(2w).
1
H), 2.83 (m, 1H), 2.94–2.98 (m, 2H), 5.08 (d, J = 5.0 Hz, 1H),
3
.44–6.46 (m, 2H), 6.85–6.87 (m, 2H), 7.26–7.30 (m, 2H), 7.75 (d,
J = 8.2 Hz, 2H).
(m, 1H), 4.72 (d, J = 6.25 Hz, 1H), 7.31 (d, J = 7.8 Hz, 2H), 7.79
7
(d, J = 8.2 Hz, 2H).
4
-Methyl-N -(2-(phenylamino)cyclopentyl)benzenesulfonamide
1
11b
(
2p). H NMR (500 MHz, CDCl
3
): d 1.26–1.46 (m, 2H), 1.68–
N-(1-Azidohexan-2-yl)-4-methylbenzenesulfonamide
(2x).
1
1.71 (m, 2H), 1.88–1.90 (m, 1H), 2.17–2.21 (m, 1H), 2.42 (s, 3H),
3.40–3.51 (m, 2H), 4.91 (d, J = 6.1 Hz, 1H), 6.53–6.58 (m, 2H),
6.70–6.73 (m, 1H), 7.11–7.15 (m, 2H), 7.26–7.27 (m, 2H), 7.76 (d,
H NMR (400 MHz, CDCl ): d 0.83 (t, J = 7.32 Hz, 3H),
3
1.06–1.26 (m, 4H), 1.34–1.48 (m, 2H), 2.43 (s, 3H), 3.30–3.40 (m,
3H), 5.01 (d, J = 7.36 Hz, 1H), 7.31 (d, J = 7.80 Hz, 2H), 7.78
(d, J = 7.84 Hz, 2H).
J = 8.2 Hz, 2H).
1
2
5d
1
11b
N ,N -Diphenylcyclohexane-1,2-diamine
400 MHz, CDCl ): d 1.22–1.28 (m, 2H), 1.38–1.42 (m, 2H),
.76–1.78 (m, 2H), 2.33–2.36 (m, 2H), 3.18–3.20 (m, 2H), 3.81 (s,
H), 6.60–6.62 (m, 4H), 6.68–6.72 (m, 2H), 7.15–7.17 (m, 4H).
(2q).
H
NMR
N-(1-Chlorohexan-2-yl)-4-methylbenzenesulfonamide
(2y).
1
(
1
2
3
H NMR (400 MHz, CDCl ): d 0.84 (t, J = 6.84 Hz, 3H),
3
1.10–1.26 (m, 4H), 1.40–1.60 (m, 2H), 2.40 (s, 3H), 3.44–3.51 (m,
3H), 5.00 (d, J = 8.32 Hz, 1H), 7.31 (d, J = 7.80 Hz, 2H), 7.77
(d, J = 7.80 Hz, 2H).
1
4
4
-Methyl-N-(1-(phenylamino)hexan-2-yl)benzenesulfonamide
1
(
2r). H NMR (400 MHz, CDCl
3
): d 0.83 (t, J = 6.84 Hz, 3H),
1
3
3
6
7
.02–1.20 (m, 4H), 1.31–1.39 (m, 1H), 1.45–1.50 (m, 1H), 2.41 (s,
Acknowledgements
H), 3.04–3.05 (m, 1H), 3.12–3.14 (m, 1H), 3.35–3.37 (m, 1H),
.92 (s, 1H), 4.79 (d, J = 7.32 Hz, 1H), 6.48 (d, J = 8.32 Hz, 2H),
.70 (t, J = 7.32 Hz, 1H), 7.10–7.15 (m, 2H), 7.20–7.26 (m, 2H),
.75 (d, J = 8.32 Hz, 2H).
We thank Professor Pengyuan Yang for his invaluable advice
during the course of this research. Financial support from the
National Natural Science Foundation of China (20502004), the
Ministry of Education of China, the Science and Technology
Commission of Shanghai Municipality (05ZR14013), and Fudan
University is gratefully acknowledged.
7
4
-Methyl-N-(1-phenyl-2-(phenylamino)ethyl)benzenesulfonamide
1
(
2s). H NMR (400 MHz, CDCl
3
): d 2.38 (s, 3H), 3.12–3.18
(
m, 1H), 3.29–3.38 (m, 1H), 4.35–4.40 (m, 1H), 5.10 (s, 1H),
5
2
8
.52 (d, J = 3.92 Hz, 1H), 7.08–7.12 (m, 2H), 7.41–7.48 (m,
H), 7.53–7.61 (m, 6H), 7.76 (d, J = 8.32 Hz, 2H), 7.83 (d, J =
.32 Hz, 2H).
References
1
For reviews of syntheses and reactions of activated and unactivated
aziridines, see: (a) A. Pawda, W. H. Pearson, B. W. Lian and S. C.
Bergmeier, in Comprehensive Heterocyclic Chemistry II, ed. A. R.
Katritzky, C. W. Rees and E. F. V. Scriven, Pergamon, New York, 1996,
vol. 1a; (b) A. Pawda and A. D. Woolhouse, in Comprehensive
Heterocyclic Chemistry, ed. W. Lwowski, Pergamon, Oxford, UK, 1984,
vol. 7; (c) D. Tanner, Angew. Chem., Int. Ed. Engl., 1994, 33, 599; (d) T.
Ibuka, Chem. Soc. Rev., 1998, 27, 145; (e) A.-H. Li, L.-X. Dai and V. K.
Aggarwal, Chem. Rev., 1997, 97, 2341; (f) H. Stamm, J. Prakt. Chem.,
7
4
-Methyl-N-(2-phenyl-2-(phenylamino)ethyl)benzenesulfonamide
1
(
3s). H NMR (400 MHz, CDCl
3
): d 2.39 (s, 3H), 3.12–3.18 (m,
1
H), 3.29–3.38 (m, 1H), 4.25–4.30 (m, 1H), 4.51 (s, 1H), 5.01 (t,
J = 6.36 Hz, 1H), 6.45 (d, J = 7.84 Hz, 2H), 6.66 (t, J = 7.36 Hz,
2
7
H), 7.01–7.12 (m, 6H), 7.50 (d, J = 7.8 Hz, 2H), 7.62 (d, J =
.8 Hz, 2H).
1
999, 319; (g) X. E. Hu, Tetrahedron, 2004, 60, 2701.
2
3
(a) H. Stamm and T. Baumann, Pharmazie, 1997, 52, 441; (b) P. Muller
and P. Nury, Org. Lett., 1999, 1, 439; (c) Z. Li, M. Fernandez and E. N.
Jacobsen, Org. Lett., 1999, 1, 1611; (d) W. Y. Lee, J. M. Salvador and K.
Bodige, Org. Lett., 2000, 2, 931; (e) M. Nakagawa and M. Kawahara,
Org. Lett., 2000, 2, 953.
N-(1-(4-Chlorophenyl)-2-(phenylamino)ethyl)-4-methylbenzene-
14
1
sulfonamide (2t). H NMR (400 MHz, CDCl
3
): d 2.34 (s, 3H),
3
1
7
7
.08–3.18 (m, 1H), 3.24–3.31 (m, 1H), 4.41–4.46 (m, 1H), 5.72 (s,
H), 5.79 (d, J = 6.36 Hz, 1H), 6.72 (d, J = 8.28 Hz, 2H), 7.14–
.28 (m, 5H), 7.41 (d, J = 8.28 Hz, 2H), 7.51 (d, J = 8.32 Hz, 2H),
.75 (d, J = 8.32 Hz, 2H).
For examples of the reaction of aziridine with alcohols or phenols, see:
(
a) B. Jacques, C. R. Josette and V. Roger, Synthesis, 1992, 288; (b) K.
Bellos and H. Stamm, J. Org. Chem., 1995, 60, 5661; (c) P. Wipf and Y.
Uto, Tetrahedron Lett., 1999, 40, 5165; (d) H. Stamm and L. Schneider,
Chem. Ber., 1974, 107, 2870.
N-(2-(4-Chlorophenyl)-2-(phenylamino)ethyl)-4-methylbenzene-
14
1
sulfonamide (3t). H NMR (400 MHz, CDCl
3
): d 2.43 (s, 3H),
4 For examples of the reaction of aziridine with thiols, see: (a) L. Antolini,
M. Bucciarelli, E. Caselli, P. Davoli, A. Forni, I. Moretti, F. Prati and
G. Torre, J. Org. Chem., 1997, 62, 8784; (b) P. E. Maligres, M. M. See,
D. Askin and P. J. Reider, Tetrahedron Lett., 1997, 38, 5253; (c) J. H.
Bae, S. H. Shin, C. S. Park and W. K. Lee, Tetrahedron, 1999, 55, 10041;
(d) T. Katagiri, M. Takahashi, Y. Fujiwara, H. Ihara and K. Uneyama,
3
1
.08–3.18 (m, 1H), 3.24–3.31 (m, 1H), 4.34–4.39 (m, 1H), 4.59 (s,
H), 5.27 (t, J = 5.4 Hz, 1H), 6.41 (d, J = 8.28 Hz, 2H), 6.66 (t,
J = 7.32 Hz, 1H), 7.01–7.08 (m, 3H), 7.20–7.24 (m, 5H), 7.69 (d,
J = 8.32 Hz, 2H).
4
234 | Org. Biomol. Chem., 2006, 4, 4231–4235
This journal is © The Royal Society of Chemistry 2006